Comparison of Different Intermittent Pneumatic Compression Devices for Deep Vein Thrombosis

April 24, 2013 updated by: Jae-Sung Choi, Seoul National University Hospital

The Influence of the Different Ways of Pneumatic Compression on Clinical and Physiologic Efficacies in Preventing Deep Vein Thrombosis: a Randomised Comparative Study

Various kinds of intermittent pneumatic compression devices (IPC) with particular ways of compression have been developed and used for prevention of deep vein thrombosis.

There are still some controversies about the physiologic properties and clinical impact of numerous issues including the variety of the cuff length, inflation rate, compression sequence, compression-relaxation cycle rate, and pressure generation characteristics.

This study is designed to compare clinical efficacies as well as venous hemodynamic improvements between Simultaneous bilateral compression with fixed venous refill time versus alternate compression with adjusted refill time

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • the patients who undergo total knee replacement arthroplasty

Exclusion Criteria:

  • (1) chronic superficial or deep venous insufficiency, (2) venous anomalies like duplication of the superficial femoral vein, (3) previous venous thromboembolism history, (4) being under anticoagulation therapy, (5) severe arteriosclerosis obliterans without palpable dorsalis pedis pulse, (6) open fracture, hemorrhagic condition, or extensive dermatitis at lower legs, (7) congestive heart failure. Additional exclusion criteria included a documented malignant tumor, because pharmacologic prophylaxis with anticoagulants would be more reasonable in this case.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Simultaneous compression+Fixed refill time
Simultaneous bilateral compression with fixed venous refill time through the whole duration of pneumatic compression
Other Names:
  • Simultaneous sequential intermittent pneumatic compression
  • Fixed venous refill time
ACTIVE_COMPARATOR: Alternate compression+Adjusted refill time
alternate bilateral compression with adjusted venous refill time which would change several times during pneumatic compression
Other Names:
  • Alternate and sequential intermittent pneumatic comression
  • Adjusted venous refill time

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of Deep Vein Thrombosis
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
Computed tomographic angiography were performed on 4th postoperative days to detect deep vein thrombosis and evaluate its extent and location.
On 4th postoperative days after total knee replacement arthroplasty

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peak Velocity
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
Doppler ultrasonography were performed to measure one of the venous hemodynamic parameters to be compared. A longitudinal scans of bilateral superficial femoral veins, just distal to the confluence of the profunda femoral veins, were performed. Baseline velocity, flow pattern, and augmented flow of 11 seconds (Simultaneous compression arm) or 12 seconds (Alternate compression arm) were recorded. Under fixed state of other ultrasound scan parameters, peak velocity (PV) was measured by determination of maximum point of the augmented waveform.
On 4th postoperative days after total knee replacement arthroplasty
Mean Velocity
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
Doppler ultrasonography were performed to measure one of the venous hemodynamic parameters to be compared. A longitudinal scans of bilateral superficial femoral veins, just distal to the confluence of the profunda femoral veins, were performed. Baseline velocity, flow pattern, and augmented flow of 11 seconds (Alternate compression arm) or 12 seconds (Simultaneous compression arm) were recorded. This is an automatically measured mean value of venous flow.
On 4th postoperative days after total knee replacement arthroplasty
Peak Volume Flow
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
Doppler ultrasonography were performed to measure one of the venous hemodynamic parameters to be compared. A longitudinal scans of bilateral superficial femoral veins, just distal to the confluence of the profunda femoral veins, were performed. Baseline velocity, flow pattern, and augmented flow of 11 seconds (Simultaneous compression arm) or 12 seconds (Alternate compression arm) were recorded. Peak volume flow (PVF) was automatically calculated with 1-second interval around the PV.
On 4th postoperative days after total knee replacement arthroplasty
Total Volume Flow
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
Doppler ultrasonography were performed to measure one of the venous hemodynamic parameters to be compared. A longitudinal scans of bilateral superficial femoral veins, just distal to the confluence of the profunda femoral veins, were performed. Baseline velocity, flow pattern, and augmented flow of 11 seconds (Simultaneous compression arm) or 12 seconds (Alternate compression arm) were recorded. Total volume flow (TVF) was automatically calculated by the software.
On 4th postoperative days after total knee replacement arthroplasty
Expelled Total Volume
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
Expelled volume was theoretically calculated value in order to figure out how much blood was squeezed by the compression for an hour; expelled total volume (ETV) = single cycle augmented TVF x cycling rate (cycles/hour).
On 4th postoperative days after total knee replacement arthroplasty
Expelled Peak Volume
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
Expelled volume was theoretically calculated value in order to figure out how much blood was squeezed by the compression for an hour; expelled peak volume (EPV) = single cycle augmented PVF x cycling rate (cycles/hour).
On 4th postoperative days after total knee replacement arthroplasty
Augmented PV
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
Enhanced peak velocity by application of intermittent pneumatic compression
On 4th postoperative days after total knee replacement arthroplasty
Augmented MV
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
Enhanced mean velocity by application of pneumatic compression
On 4th postoperative days after total knee replacement arthroplasty
Augmented PVF
Time Frame: On 4th postoperative days after total knee replacement arthroplasty
Enhanced peak volume flow by application of pneumatic compression
On 4th postoperative days after total knee replacement arthroplasty
Augmented TVF
Time Frame: on 4th postoperative day after total knee replacement arthroplasty
Enhanced total volume flow by application of pneumatic compression
on 4th postoperative day after total knee replacement arthroplasty
Cycling Rate
Time Frame: on 4th postoperative day after total knee replacement arthroplasty
Number of cuff inflation-deflation cycle during an hour. In group SF, the cycling rate is fixed as 90 cycles/hour, but in group AA, it is variable according to the individual venous refill time.
on 4th postoperative day after total knee replacement arthroplasty

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jae-Sung Choi, Ph.D., SMG-SNU Boramae Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2012

Primary Completion (ACTUAL)

January 1, 2013

Study Completion (ACTUAL)

January 1, 2013

Study Registration Dates

First Submitted

January 27, 2013

First Submitted That Met QC Criteria

January 27, 2013

First Posted (ESTIMATE)

January 30, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

May 1, 2013

Last Update Submitted That Met QC Criteria

April 24, 2013

Last Verified

April 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Venous Thrombosis

Clinical Trials on DVT-3000

Subscribe